Documento de consenso de la Sociedad Española de Neurología sobre el uso de medicamentos en esclerosis múltiple: escalado terapéutico-Reference-Cited by-同舟云学术

Documento de consenso de la Sociedad Española de Neurología sobre el uso de medicamentos en esclerosis múltiple: escalado terapéutico

Published:2010-07 Issue:6 Volume:25 Page:378-390
ISSN:0213-4853
Container-title:Neurología
language:es
Short-container-title:Neurología

Author:

García Merino A.,Fernández O.,Montalbán X.,de Andrés C.,Arbizu T.

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference49 articles.

1. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial;Neurology.,1993

2. Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind, placebo-controlled trial. 1995;Johnson;Neurology.,2001

3. Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis;Lancet.,1998

4. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG). Ann Neurol. 1996; 39:285–94.

5. How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?;Brown;Neurology.,2007

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Documento de consenso de la Sociedad Española de Neurología sobre el tratamiento de la esclerosis múltiple y manejo holístico del paciente 2023;Neurología;2024-03

2. Consensus statement of the Spanish Society of Neurology on the treatment of multiple sclerosis and holistic patient management in 2023;Neurología (English Edition);2024-03

3. Nursing care of patients with multiple sclerosis during the COVID-19 pandemic;Revista Científica de la Sociedad de Enfermería Neurológica (English ed.);2022-09

4. Atención del personal de enfermería a pacientes con esclerosis múltiple durante la pandemia de la COVID-19;Revista Científica de la Sociedad Española de Enfermería Neurológica;2022-06

5. Interferon beta 1a (Rebif®) in relapsing remitting multiple sclerosis;Drug Development Research;2021-02-15